REFERENCES
- Jones P W, Bosh T K. Changes in quality of life in COPD patients treated with salmeterol. Am J Resp Crit Care Med 1997; 155:1283–1289. [PUBMED], [INFOTRIEVE], [CSA]
- Casaburi R, Mahler D A, Jones P W, Wanner A, San Pedro G, ZuWallack R L, Menjonge S S, Serby C W, Witek T. A long-term evaluation of once daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19:209–216. [CROSSREF]
- Vincken W, van Noord J A, Greefhorst A P, Bantje T A, Kesten S, Korducki L, Cornelissen P J, Dutch/Belgian Tiotropium Study G. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002; 19(2):209–216. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, Peterson S, Olsson H. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003; 21:74–81. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Calverley P MA, Pauwels R, Vestbo J, Jones P W, Pride N, Gulsvick A. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease. Lancet 2003; 361:449. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Calverley P MA, Boonsawat W, Cseke Z, Zhong N, Peterson S, Olsson H. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003; 22:912–919. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Griffiths T L, Burr M L, Campbell I A, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor P J, Payne N, Newcombe R G, Ionescu A A, Thomas J, Tunbridge J. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000; 355(9201):362–368. [PUBMED], [INFOTRIEVE], [CROSSREF]
- National Emphysema Treatment Trial Research Group. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. NEJM 2003; 348:2092–2102. [CROSSREF]
- Jones P W. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56:880–887. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jones P W, Quirk F H, Baveystock C M, Littlejohns P. A self-complete measure for chronic airflow limitation—the St George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321–1327. [PUBMED], [INFOTRIEVE]
- Jones P W. Interpreting thresholds for a clinically significant changes in health status in asthma and COPD. Eur Respir J 2002; 19:398–404. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jones P W, Quirk F H, Baveystock C M. The St George's Respiratory Questionnaire. Respir Med 1991; 85(suppl B):25–31. [PUBMED], [INFOTRIEVE]
- Osman L M, Godden D J, Friend J AR, Legge J S, Douglas J G. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997; 52:67–71. [PUBMED], [INFOTRIEVE]
- Bestall J C, Paul E A, Garrod R, Garnham R, Jones P W, Wedzicha J A. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54(7):581–586. [PUBMED], [INFOTRIEVE]
- Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Félez M, Khalaf A, Marrades R M, Monsó E, Serra-Batlles J, Antó J M. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:680–685. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmnary disease. Am J Respir Crit Care Med 2003; 167:544–549. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schünemann H J, Griffith L, Jaeschke R, Goldstein R S, Stubbing D, Guyatt G H. Evaluation of the minumum important difference for the feeling thermometer and the St George's Respiratory Questionnaire in patients with chronic airflow limitation. J Clin Epidemiol 2003; 56:1170–1176. [CSA], [CROSSREF]
- Norman G R, Sloan J A, Wyrwich K W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41:582–592. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dahl R, Greefhorst L APM, Nowak D, Nonikov V, Byrne A M, Thomson M H, Till D, Della Cioppa G. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 778–784. [PUBMED], [INFOTRIEVE], [CSA]
- Jaeschke R, Singer J, Guyatt G H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10:407–415. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Norman G R, Sridhar F G, Guyatt G H, Walter S D. Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care 2001; 39:1039–1047. [PUBMED], [INFOTRIEVE], [CROSSREF]